RCMI Coordinating Center (RCMI CC) Header Logo

Rajesh Singh

Title
Faculty RankAssociate Professor
InstitutionMorehouse School of Medicine
DepartmentMicrobiology, Biochemistry, & Immunology
Address720 Westveiw Drive, SW
Atlanta GA 30310
Phone4047526661
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    SC1CA193758     (SINGH, RAJESH)Sep 1, 2014 - Aug 31, 2021
    NIH
    Targeted Nanotherapy for prostate cancer
    Role: Principal Investigator
    R01CA256724     (SINGH, SHAILESH)Jul 1, 2022 - Dec 31, 2027
    NIH
    The interplay of social and molecular determinants in lung cancer disparity
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sahgal M, Saini N, Jaggi V, Brindhaa NT, Kabdwal M, Singh RP, Prakash A. Antagonistic potential and biological control mechanisms of?Pseudomonas strains against?banded leaf and sheath blight disease of maize. Sci Rep. 2024 06 12; 14(1):13580. PMID: 38866928.
      Citations:    Fields:    Translation:AnimalsCellsPHPublic Health
    2. Kaur P, Singh SK, Mishra MK, Singh S, Singh R. Promising Combinatorial Therapeutic Strategies against Non-Small Cell Lung Cancer. Cancers (Basel). 2024 Jun 12; 16(12). PMID: 38927911.
      Citations:    
    3. Talukdar S, Singh SK, Mishra MK, Singh R. Emerging Trends in Nanotechnology for Endometriosis: Diagnosis to Therapy. Nanomaterials (Basel). 2024 Jun 05; 14(11). PMID: 38869601.
      Citations:    
    4. Brock BA, Mir H, Flenaugh EL, Oprea-Ilies G, Singh R, Singh S. Social and Biological Determinants in Lung Cancer Disparity. Cancers (Basel). 2024 Jan 31; 16(3). PMID: 38339362.
      Citations:    
    5. McFadden M, Singh SK, Kinnel B, Varambally S, Singh R. The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer. J Ovarian Res. 2023 Nov 21; 16(1):220. PMID: 37990267.
      Citations:    Fields:    Translation:HumansCells
    6. McKinney LP, Singh R, Jordan IK, Varambally S, Dammer EB, Lillard JW. Transcriptome Analysis Identifies Tumor Immune Microenvironment Signaling Networks Supporting Metastatic Castration-Resistant Prostate Cancer. Onco (Basel). 2023 Jun; 3(2):81-95. PMID: 38435029.
      Citations:    
    7. Kinnel B, Singh SK, Oprea-Ilies G, Singh R. Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer. Cancers (Basel). 2023 Feb 19; 15(4). PMID: 36831661.
      Citations:    
    8. Singh SK, Singh R. Nanotherapy: targeting the tumour microenvironment. Nat Rev Cancer. 2022 05; 22(5):258. PMID: 35236941.
      Citations: 7     Fields:    Translation:Humans
    9. Adebayo OO, Dammer EB, Dill CD, Adebayo AO, Oseni SO, Griffen TL, Ohandjo AQ, Yan F, Jain S, Barwick BG, Singh R, Boise LH, Lillard JW. Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients. Cancers (Basel). 2022 Apr 29; 14(9). PMID: 35565356.
      Citations:    
    10. Singh SK, Singh R. Cytokines and Chemokines in Cancer Cachexia and Its Long-Term Impact on COVID-19. Cells. 2022 02 08; 11(3). PMID: 35159388.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    11. Haynes T, Oprea-Ilies G, Manne U, Singh R, Singh S, Mir H. The interplay of pineal hormones and socioeconomic status leading to colorectal cancer disparity. Transl Oncol. 2022 Feb; 16:101330. PMID: 34990909.
      Citations:    
    12. Singh SK, Singh R. Surface Plasmon Resonance, a Novel Technique for Sensing Cancer Biomarker: Folate Receptor and Nanoparticles Interface. Methods Mol Biol. 2022; 2413:211-228. PMID: 35044668.
      Citations: 1     Fields:    Translation:Humans
    13. McFadden M, Singh SK, Oprea-Ilies G, Singh R. Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers. Cancers (Basel). 2021 Oct 31; 13(21). PMID: 34771642.
      Citations:    
    14. Singh SK, Singh S, Singh R. Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia. J Ovarian Res. 2021 Sep 27; 14(1):126. PMID: 34579761.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    15. Singh SK, Apata T, Singh S, McFadden M, Singh R. Clinical Implication of Metformin in Relation to Diabetes Mellitus and Ovarian Cancer. Biomedicines. 2021 Aug 16; 9(8). PMID: 34440224.
      Citations:    
    16. Mir H, Kapur N, Gales DN, Sharma PK, Oprea-Ilies G, Johnson AT, Singh R, Singh S. CXCR6-CXCL16 Axis Promotes Breast Cancer by Inducing Oncogenic Signaling. Cancers (Basel). 2021 Jul 16; 13(14). PMID: 34298782.
      Citations:    
    17. Singh SK, Gordetsky JB, Bae S, Acosta EP, Lillard JW, Singh R. Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer. Cells. 2020 08 27; 9(9). PMID: 32867229.
      Citations: 15     Fields:    Translation:HumansCells
    18. Darling HS, Viswanath S, Singh R, Ranjan S, Pathi N, Rathore A, Pathak A, Sud R. A clinico-epidemiological, pathological, and molecular study of lung cancer in Northwestern India. J Cancer Res Ther. 2020 Jul-Sep; 16(4):771-779. PMID: 32930117.
      Citations: 1     Fields:    Translation:Humans
    19. Singh SK, Mishra MK, Rivers BM, Gordetsky JB, Bae S, Singh R. Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular Carcinoma. Cancers (Basel). 2020 Apr 05; 12(4). PMID: 32260550.
      Citations:    
    20. Noel B, Singh SK, Lillard JW, Singh R. Role of natural compounds in preventing and treating breast cancer. Front Biosci (Schol Ed). 2020 03 01; 12(1):137-160. PMID: 32114452.
      Citations: 16     Fields:    Translation:HumansAnimals
    21. Singh SK, Singh R. Liver cancer incidence and mortality: Disparities based on age, ethnicity, health and nutrition, molecular factors, and geography. Cancer Health Disparities. 2020 Mar; 4:e1-e10. PMID: 34164612.
      Citations:    
    22. Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 2020 01; 1873(1):188314. PMID: 31682895.
      Citations: 456     Fields:    Translation:Humans
    23. Singh SK, Apata T, Gordetsky JB, Singh R. Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway. Cancers (Basel). 2019 Sep 18; 11(9). PMID: 31540423.
      Citations:    
    24. Singh SK, Mishra MK, Singh R. Hypoxia-inducible factor-1a induces CX3CR1 expression and promotes the epithelial to mesenchymal transition (EMT) in ovarian cancer cells. J Ovarian Res. 2019 May 10; 12(1):42. PMID: 31077234.
      Citations: 19     Fields:    Translation:HumansCells
    25. Singh SK, Lillard JW, Singh R. Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer. Cancer Lett. 2018 07 28; 427:49-62. PMID: 29678549.
      Citations: 39     Fields:    Translation:HumansCells
    26. Singh SK, Mishra MK, Eltoum IA, Bae S, Lillard JW, Singh R. CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells. Sci Rep. 2018 01 22; 8(1):1323. PMID: 29358632.
      Citations: 87     Fields:    Translation:HumansCells
    27. Garg SK, Campbell JP, Anugwom C, Wadhwa V, Singh R, Gupta N, Sanaka MR. Incidence and Predictors of Readmissions in Acute Pancreatitis: A Nationwide Analysis. Pancreas. 2018 01; 47(1):46-54. PMID: 29215534.
      Citations: 13     Fields:    Translation:Humans
    28. Singh R, Mishra MK, Aggarwal H. Inflammation, Immunity, and Cancer. Mediators Inflamm. 2017; 2017:6027305. PMID: 29234189.
      Citations: 106     Fields:    Translation:HumansAnimals
    29. Akpalu D, Newman G, Brice M, Powell M, Singh R, Quarshie A, Ofili E, Fonger J, Chronos N, Feldman D. Matrix Signaling Subsequent to a?Myocardial Infarction: A Proteomic Profile of Tissue Factor Microparticles. JACC Basic Transl Sci. 2017 Oct; 2(5):529-542. PMID: 30062169.
      Citations:    
    30. Singh SK, Singh S, Lillard JW, Singh R. Drug delivery approaches for breast cancer. Int J Nanomedicine. 2017; 12:6205-6218. PMID: 28883730.
      Citations: 59     Fields:    Translation:Humans
    31. Singh SK, Banerjee S, Acosta EP, Lillard JW, Singh R. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway. Oncotarget. 2017 Mar 07; 8(10):17216-17228. PMID: 28212547.
      Citations: 92     Fields:    Translation:HumansCells
    32. Banerjee S, Singh SK, Chowdhury I, Lillard JW, Singh R. Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer. Front Biosci (Elite Ed). 2017 03 01; 9(2):235-245. PMID: 28199187.
      Citations: 41     Fields:    Translation:HumansCells
    33. Singh SK, Lillard JW, Singh R. Molecular basis for prostate cancer racial disparities. Front Biosci (Landmark Ed). 2017 01 01; 22(3):428-450. PMID: 27814623.
      Citations: 15     Fields:    Translation:Humans
    34. Singh R, Kapur N, Mir H, Singh N, Lillard JW, Singh S. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and av?3 integrin clustering. Oncotarget. 2016 Feb 09; 7(6):7343-53. PMID: 26799186.
      Citations: 37     Fields:    Translation:HumansCells
    35. Mir H, Kapur N, Singh R, Sonpavde G, Lillard JW, Singh S. Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors. Cell Cycle. 2016; 15(6):819-26. PMID: 27029529.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    36. Omosun Y, McKeithen D, Ryans K, Kibakaya C, Blas-Machado U, Li D, Singh R, Inoue K, Xiong ZG, Eko F, Black C, Igietseme J, He Q. Interleukin-10 modulates antigen presentation by dendritic cells through regulation of NLRP3 inflammasome assembly during Chlamydia infection. Infect Immun. 2015 Dec; 83(12):4662-72. PMID: 26371131.
      Citations: 18     Fields:    Translation:AnimalsCells
    37. Mir H, Singh R, Kloecker GH, Lillard JW, Singh S. CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases. Oncotarget. 2015 Apr 30; 6(12):9985-98. PMID: 25888629.
      Citations: 16     Fields:    Translation:HumansCells
    38. Batra M, Sharma R, Chandra V, Aggarwal M, Agarwal U, Gupta P, Singh RP, Tomar S. In silico and proteomic analysis of protein methyltransferase CheR from Bacillus subtilis. Int J Biol Macromol. 2015; 77:168-80. PMID: 25799883.
      Citations: 1     Fields:    Translation:Cells
    39. Gupta P, Sharma PK, Mir H, Singh R, Singh N, Kloecker GH, Lillard JW, Singh S. CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis. Oncotarget. 2014 Oct 30; 5(20):10170-9. PMID: 25296976.
      Citations: 28     Fields:    Translation:HumansCells
    40. Singh R, Gupta P, Kloecker GH, Singh S, Lillard JW. Expression and clinical significance of CXCR5/CXCL13 in human non-small cell lung carcinoma. Int J Oncol. 2014 Dec; 45(6):2232-40. PMID: 25271023.
      Citations: 41     Fields:    Translation:HumansCells
    41. Singh R, Gupta P, Sharma PK, Ades EW, Hollingshead SK, Singh S, Lillard JW. Prediction and characterization of helper T-cell epitopes from pneumococcal surface adhesin A. Immunology. 2014 Apr; 141(4):514-30. PMID: 24138116.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    42. El-Haibi CP, Sharma P, Singh R, Gupta P, Taub DD, Singh S, Lillard JW. Differential G protein subunit expression by prostate cancer cells and their interaction with CXCR5. Mol Cancer. 2013 Jun 18; 12:64. PMID: 23773523.
      Citations: 29     Fields:    Translation:HumansCells
    43. Akama T, Virtucio C, Dong C, Kimura R, Zhang YK, Nieman JA, Sharma R, Lu X, Sales M, Singh R, Wu A, Fan XQ, Liu L, Plattner JJ, Jarnagin K, Freund YR. Structure-activity relationships of 6-(aminomethylphenoxy)-benzoxaborole derivatives as anti-inflammatory agent. Bioorg Med Chem Lett. 2013 Mar 15; 23(6):1680-3. PMID: 23411072.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    44. Hernandez V, Cr?pin T, Palencia A, Cusack S, Akama T, Baker SJ, Bu W, Feng L, Freund YR, Liu L, Meewan M, Mohan M, Mao W, Rock FL, Sexton H, Sheoran A, Zhang Y, Zhang YK, Zhou Y, Nieman JA, Anugula MR, Keramane el M, Savariraj K, Reddy DS, Sharma R, Subedi R, Singh R, O'Leary A, Simon NL, De Marsh PL, Mushtaq S, Warner M, Livermore DM, Alley MR, Plattner JJ. Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria. Antimicrob Agents Chemother. 2013 Mar; 57(3):1394-403. PMID: 23295920.
      Citations: 76     Fields:    Translation:HumansAnimalsCells
    45. Freund YR, Akama T, Alley MR, Antunes J, Dong C, Jarnagin K, Kimura R, Nieman JA, Maples KR, Plattner JJ, Rock F, Sharma R, Singh R, Sanders V, Zhou Y. Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center. FEBS Lett. 2012 Sep 21; 586(19):3410-4. PMID: 22841723.
      Citations: 24     Fields:    Translation:HumansCells
    46. Borgegard T, Jur?us A, Olsson F, Rosqvist S, Sabirsh A, Rotticci D, Paulsen K, Klintenberg R, Yan H, Waldman M, Stromberg K, Nord J, Johansson J, Regner A, Parpal S, Malinowsky D, Radesater AC, Li T, Singh R, Eriksson H, Lundkvist J. First and second generation ?-secretase modulators (GSMs) modulate amyloid-? (A?) peptide production through different mechanisms. J Biol Chem. 2012 Apr 06; 287(15):11810-9. PMID: 22334705.
      Citations: 34     Fields:    Translation:HumansAnimalsCells
    47. El-Haibi CP, Singh R, Gupta P, Sharma PK, Greenleaf KN, Singh S, Lillard JW. Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate Cancer. J Proteomics Bioinform. 2012; 5(8):177-184. PMID: 24009409.
      Citations:    
    48. Singh R, Singh S, Briles DE, Taub DD, Hollingshead SK, Lillard JW. CCL5-independent helper T lymphocyte responses to immuno-dominant pneumococcal surface protein A epitopes. Vaccine. 2012 Feb 01; 30(6):1181-90. PMID: 22178100.
      Citations:    Fields:    Translation:AnimalsCells
    49. Moktar A, Singh R, Vadhanam MV, Ravoori S, Lillard JW, Gairola CG, Gupta RC. Cigarette smoke condensate-induced oxidative DNA damage and its removal in human cervical cancer cells. Int J Oncol. 2011 Oct; 39(4):941-7. PMID: 21720711.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    50. El-Haibi CP, Singh R, Sharma PK, Singh S, Lillard JW. CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation. Cell Prolif. 2011 Aug; 44(4):311-9. PMID: 21645150.
      Citations: 42     Fields:    Translation:HumansCells
    51. Singh R, Lillard JW, Singh S. Chemokines: key players in cancer progression and metastasis. Front Biosci (Schol Ed). 2011 06 01; 3(4):1569-82. PMID: 21622291.
      Citations: 33     Fields:    Translation:Humans
    52. Singh R, Stockard CR, Grizzle WE, Lillard JW, Singh S. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer. Int J Oncol. 2011 Aug; 39(2):373-81. PMID: 21637913.
      Citations: 30     Fields:    Translation:HumansCells
    53. Shankar E, Vykhovanets EV, Vykhovanets OV, Maclennan GT, Singh R, Bhaskaran N, Shukla S, Gupta S. High-fat diet activates pro-inflammatory response in the prostate through association of Stat-3 and NF-?B. Prostate. 2012 Feb; 72(3):233-43. PMID: 21604287.
      Citations: 32     Fields:    Translation:AnimalsCells
    54. Johnson-Holiday C, Singh R, Johnson EL, Grizzle WE, Lillard JW, Singh S. CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion. World J Surg Oncol. 2011 May 03; 9:46. PMID: 21539750.
      Citations: 25     Fields:    Translation:HumansCells
    55. Johnson-Holiday C, Singh R, Johnson E, Singh S, Stockard CR, Grizzle WE, Lillard JW. CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion. Int J Oncol. 2011 May; 38(5):1279-85. PMID: 21344163.
      Citations: 47     Fields:    Translation:HumansCells
    56. Johnson EL, Singh R, Singh S, Johnson-Holiday CM, Grizzle WE, Partridge EE, Lillard JW. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion. World J Surg Oncol. 2010 Jul 22; 8:62. PMID: 20649989.
      Citations: 22     Fields:    Translation:HumansCells
    57. Johnson EL, Singh R, Johnson-Holiday CM, Grizzle WE, Partridge EE, Lillard JW, Singh S. CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion. J Ovarian Res. 2010 Jun 17; 3:15. PMID: 20565782.
      Citations: 20     Fields:    
    58. El Haibi CP, Sharma PK, Singh R, Johnson PR, Suttles J, Singh S, Lillard JW. PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells. Mol Cancer. 2010 Apr 22; 9:85. PMID: 20412587.
      Citations: 31     Fields:    Translation:HumansCells
    59. VanCleave TT, Moore JH, Benford ML, Brock GN, Kalbfleisch T, Baumgartner RN, Lillard JW, Kittles RA, Kidd LC. Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk. Prostate. 2010 Mar 01; 70(4):341-52. PMID: 19908237.
      Citations: 25     Fields:    Translation:Humans
    60. Singh R, Singh S, Sharma PK, Singh UP, Briles DE, Hollingshead SK, Lillard JW. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A. PLoS One. 2010 Feb 25; 5(2):e9432. PMID: 20195541.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    61. Singh S, Singh R, Singh UP, Rai SN, Novakovic KR, Chung LW, Didier PJ, Grizzle WE, Lillard JW. Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines. Int J Cancer. 2009 Nov 15; 125(10):2288-95. PMID: 19610059.
      Citations: 39     Fields:    Translation:HumansCells
    62. Singh S, Singh R, Sharma PK, Singh UP, Rai SN, Chung LW, Cooper CR, Novakovic KR, Grizzle WE, Lillard JW. Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion. Cancer Lett. 2009 Sep 28; 283(1):29-35. PMID: 19375853.
      Citations: 48     Fields:    Translation:HumansCells
    63. Singh R, Lillard JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009 Jun; 86(3):215-23. PMID: 19186176.
      Citations: 521     Fields:    Translation:HumansAnimals
    64. Singh R, Singh S, Lillard JW. Past, present, and future technologies for oral delivery of therapeutic proteins. J Pharm Sci. 2008 Jul; 97(7):2497-523. PMID: 17918721.
      Citations: 31     Fields:    Translation:Cells
    65. Singh UP, Singh R, Singh S, Karls RK, Quinn FD, Taub DD, Lillard JW. CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis. BMC Immunol. 2008 Jun 04; 9:25. PMID: 18533024.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    66. Singh UP, Singh S, Singh R, Cong Y, Taub DD, Lillard JW. CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition. J Interferon Cytokine Res. 2008 Jan; 28(1):31-43. PMID: 18370870.
      Citations: 30     Fields:    Translation:AnimalsCells
    67. Zuba-Surma EK, Kucia M, Abdel-Latif A, Dawn B, Hall B, Singh R, Lillard JW, Ratajczak MZ. Morphological characterization of very small embryonic-like stem cells (VSELs) by ImageStream system analysis. J Cell Mol Med. 2008 Jan-Feb; 12(1):292-303. PMID: 18031297.
      Citations: 51     Fields:    Translation:AnimalsCells
    68. Singh UP, Venkataraman C, Singh R, Lillard JW. CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication. Endocr Metab Immune Disord Drug Targets. 2007 Jun; 7(2):111-23. PMID: 17584151.
      Citations: 50     Fields:    Translation:HumansAnimals
    69. Singh UP, Singh S, Singh R, Karls RK, Quinn FD, Potter ME, Lillard JW. Influence of Mycobacterium avium subsp. paratuberculosis on colitis development and specific immune responses during disease. Infect Immun. 2007 Aug; 75(8):3722-8. PMID: 17502388.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    70. Palaniappan R, Singh S, Singh UP, Singh R, Ades EW, Briles DE, Hollingshead SK, Royal W, Sampson JS, Stiles JK, Taub DD, Lillard JW. CCL5 modulates pneumococcal immunity and carriage. J Immunol. 2006 Feb 15; 176(4):2346-56. PMID: 16455992.
      Citations: 21     Fields:    Translation:AnimalsCells
    Singh's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (365)
    Explore
    _
    Co-Authors (10)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support